Devyser secures a four-year tender in France for Devyser Compact
Devyser, a leading provider of advanced genetic testing solutions, has been awarded a new tender in...
News | May 4, 2016
Devyser Holding AB announced at its annual general meeting yesterday the appointment of two new board members, Ernst Westman and Lars Höckenström.
Ernst Westman is CEO of the boule diagnostics group since 22 years. Lars Höckenström is currently a senior adviser at Stockholm corporate finance. Chairman of the board Mia Arnhult comments:
"I am delighted to have Ernst Westman and Lars Höckenström on Devyser’s board. Their combined experience and expertise within both the diagnostics industry and finance will greatly benefit our work.
Devyser, a leading provider of advanced genetic testing solutions, has been awarded a new tender in...
Read More
Devyser is proud to announce that One Lambda Devyser Chimerism and Advyser Chimerism have been...
Read More
Devyser today announced that the Centers for Medicare & Medicaid Services (CMS) has issued its...
Read More
Devyser today announced the enrollment of the first patient in its Devyser Accept cfDNA clinical...
Read More